Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Hair follicles and sweat glands show different keratin staining patterns.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Stromal cells in melanoma promote tumor growth and spread.

Immunotherapies for non-small cell lung cancer show promise in improving treatment and reducing side effects.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Multiphoton microscopy helps understand and improve vitiligo treatments by visualizing skin cell changes.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Some hair proteins are specific to hair, while others are also found in skin cells.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Early recognition of symptoms is crucial for treating IPEX syndrome with a stem cell transplant.

Immune system changes may contribute to female pattern hair loss.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.